A detailed history of Black Rock Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,341,508 shares of AXNX stock, worth $308 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,341,508
Previous 4,285,883 1.3%
Holding current value
$308 Million
Previous $296 Million 1.26%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$66.47 - $69.65 $3.7 Million - $3.87 Million
55,625 Added 1.3%
4,341,508 $292 Million
Q1 2024

May 10, 2024

BUY
$56.67 - $69.36 $5.44 Million - $6.66 Million
96,066 Added 2.29%
4,285,883 $296 Million
Q4 2023

Feb 13, 2024

BUY
$49.38 - $63.75 $13.6 Million - $17.6 Million
275,707 Added 7.04%
4,189,817 $261 Million
Q3 2023

Nov 13, 2023

BUY
$48.64 - $62.51 $7.32 Million - $9.41 Million
150,483 Added 4.0%
3,914,110 $220 Million
Q2 2023

Aug 11, 2023

BUY
$47.99 - $60.21 $7.81 Million - $9.79 Million
162,665 Added 4.52%
3,763,627 $190 Million
Q1 2023

May 12, 2023

SELL
$52.6 - $67.34 $1.57 Million - $2.01 Million
-29,881 Reduced 0.82%
3,600,962 $196 Million
Q4 2022

Feb 13, 2023

BUY
$59.56 - $76.6 $7.5 Million - $9.64 Million
125,901 Added 3.59%
3,630,843 $227 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $5.67 Million - $7.65 Million
97,908 Added 2.87%
3,504,942 $247 Million
Q2 2022

Aug 12, 2022

SELL
$39.5 - $64.42 $2.32 Million - $3.78 Million
-58,753 Reduced 1.7%
3,407,034 $193 Million
Q1 2022

May 12, 2022

SELL
$43.74 - $62.76 $2.61 Million - $3.75 Million
-59,762 Reduced 1.7%
3,465,787 $217 Million
Q4 2021

Feb 10, 2022

BUY
$50.01 - $73.35 $6.79 Million - $9.95 Million
135,682 Added 4.0%
3,525,549 $197 Million
Q3 2021

Nov 09, 2021

BUY
$59.21 - $78.66 $23.9 Million - $31.8 Million
404,439 Added 13.55%
3,389,867 $221 Million
Q2 2021

Aug 11, 2021

BUY
$51.39 - $66.9 $153 Million - $200 Million
2,985,428 New
2,985,428 $189 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.